WESPAC Advisors SoCal’s DexCom DXCM Stock Holding History

WESPAC Advisors SoCal’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,200	Closed	-$35K	–	141
2019 Q1	$35K	Hold	1,200	–	–	0.02%	132
2018 Q4	$35K	Hold	1,200	–	–	0.02%	137
2018 Q3	$42K	Buy	+1,200	New	+$37.2K	0.02%	134
2018 Q2	–	Sell	-1,200	Closed	-$22K	–	126
2018 Q1	$22K	Hold	1,200	–	–	0.01%	159
2017 Q4	$17K	Hold	1,200	–	–	0.01%	165
2017 Q3	$14K	Hold	1,200	–	–	0.01%	185
2017 Q2	$21K	Hold	1,200	–	–	0.01%	148
2017 Q1	$25.4K	Hold	1,200	–	–	0.02%	139
2016 Q4	$17.9K	Hold	1,200	–	–	0.01%	154
2016 Q3	$26.3K	Hold	1,200	–	–	0.02%	137
2016 Q2	$23.8K	Hold	1,200	–	–	0.02%	150
2016 Q1	$20.4K	Hold	1,200	–	–	0.02%	156
2015 Q4	$24K	Buy	+1,200	New	+$25K	0.02%	151

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

WESPAC Advisors SoCal's DXCM Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of DexCom (DXCM) in Q2 2019, closing a stake of 1,200 shares — an estimated $35K sold.

WESPAC Advisors SoCal first reported a position in DXCM in Q4 2015 and held it in 13 quarters. The position peaked at $42K in Q3 2018. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

WESPAC Advisors SoCal reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
WESPAC Advisors SoCal sold 1,200 DexCom shares in Q2 2019, an estimated $35K.
WESPAC Advisors SoCal first reported a position in DexCom in Q4 2015 and held it in 13 quarters.
WESPAC Advisors SoCal's DexCom position peaked at $42K in Q3 2018.
418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.